Please assess the completion status of the following clinical trial:

Trial Title: Flexor Tenosynovectomy to Treat Recurrent Carpal Tunnel Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult patients (\> 18 years)~* Patient of The Plastic Surgery Group/Hayes Hand Center~* Previous diagnosis of Carpal Tunnel Syndrome~* Diagnosis of Recurrent Carpal Tunnel Syndrome~* Underwent primary carpal tunnel release~* Undergoing isolated flexor tenosynovectomy as secondary procedure~Exclusion Criteria:~* Had incomplete primary release of transverse carpal ligament~* Had documented neuroma upon re-exploration~* Had other soft tissue tumor within carpal tunnel or providing reasonable contribution to neurologic symptoms~* Experienced fracture or other traumatic injury to wrist after primary carpal tunnel release~* Diagnosis of osteomyelitis, infectious tenosynovitis or other infectious etiology to area of interest after primary procedure~* Diagnosis of rheumatoid arthritis, psoriatic arthritis, or other inflammatory arthropathy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Flexor tenosynovectomy surgery (Type: None): Adult patients who will be undergoing flexor tenosynovectomy for the treatment of recurrent carpal tunnel syndrome and who have already undergone primary carpal tunnel release surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).